ACTRN12619000833167Recruiting未知
A safety and physiology-study of a near isotonic maintenance fluid containing 1 % glucose to infants (1-12 months old)
Department of Paediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital0 sites375 target enrollmentStarted: June 11, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 375
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 1 Months to 12 Months (—)
- Sex
- All
Inclusion Criteria
- •Infants undergoing surgery at Karolinska University Hospital, Stockholm Sweden.
Exclusion Criteria
- •Metabolic and/or endocrinology disease, liver disease affecting liver function, malnutrition, small for gestational age at birth (>2 standard deviations), ongoing medication with beta-blocker, preoperatively parenteral nutrition, preoperative glucose infusion of > 6 hours, plasma glucose concentration < 3.0 mmol/L at induction of anesthesia.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A study comparing the effectiveness of two intravenous fluids, Sterofundin and Ringers Lactate in children undergoing surgeries.CTRI/2020/06/026011Department of Anaesthesiology SMS Medical College
Unknown
Phase 1
Radiological and biochemical effects of isokinetic training on chronic low back paiCTRI/2020/02/023343Prince Sattam Bin Abdul Aziz University
Completed
Not Applicable
Study of the Safety and Efficacy of an Iontophoretic Device to Treat Recurrent Herpes LabialisHerpes labialisISRCTN83097613Klearsen Corporation (USA)13
Completed
Phase 1
Safety evaluation and effect of consumption of Isochrysis gabana and dill tea against oxidative stress in volunteersHealthy conditionsIsochrysis gabanaDilloxidative stressTCTR20201223004Agricultural Research Development Agency (ARDA)68
Completed
Not Applicable
Safety profile and pharmacokinetics of a synthetic cannabinoid (JWH-018)JWH-018, synthetic cannabinoid, safety, pharmacokineticsNL-OMON29562Maastricht University55